Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 247
Filter
1.
Health sci. dis ; 24(1): 77-81, 2023. figures, tables
Article in French | AIM | ID: biblio-1411352

ABSTRACT

Introduction. La limbo-conjonctivite endémique des tropiques (LCET) est une kérato-conjonctivite allergique récidivante du jeune enfant qui s'améliore après la puberté mais peut persister. Le but de cette étude était de déterminer le profil évolutif de la LCETdans notre pratique. Méthodologie. Étude longitudinale descriptive menée dans l'unité d'ophtalmologie de l'Hôpital Gynéco-Obstétrique et Pédiatrique de Yaoundé. Tous les dossiers de LCET reçus de janvier 2011 à décembre 2019 avec un recul d'aumoins deux ans de suivi ont été recensés. Les patients qui ont accepté de participer après apptéléphonique ont été inclus de janvier à mai 2021.Les variables d'étudeétaient: âge, sexe, acuité visuelle (AV), caractéristiques de la LCET selon Diallo, pronostic fonctionnel et anatomique en post puberté (plus de 15 ans). Résultats. Au total,30 patients (60 yeux) ont été étudiés. Le sex-ratio était de 2. La moyenne d'âge était de 15 ans ± 9 ans. Initialement, le prurit était le maitre symptôme (96,7%). Après un recul moyen de cinq ans, l'AV était utile chez tous les patients (100%) et la LCET stade 2 plus représentée (60%). Le nombre moyen de récidives était de trois. Les patients post pubertaires on eu une amélioration anatomique dans 56.7% des caset une aggravation dans 10%des casConclusion. Notre travail confirme l'amélioration post pubertaire globale de la LCET, nonobstant quelques formes graves depronosticpéjoratif pour la fonction visuelle.


Introduction. Tropical endemiclimbo-conjunctivitis (TELC) is a recurrent allergic kerato-conjunctivitis in young children which improves after puberty but may persist. The aim of this study was to determine the evolutionof TELCin our setting. Methodology. This was a longitudinal descriptive study conducted in the ophthalmology unit of the Yaoundé Gyneco-Obstetric and Pediatric Hospital. All TELC files received from January 2011 to December 2019 with a follow-up of at least two years of follow-up were identified. Patients who agreed to participate after a phone call were included from January to May 2021. The variables of interest were: age, sex, visual acuity (VA), TELC classification according to Diallo, functional and anatomical prognosis in post puberty (more than 15 years).A totalof30 patients (60 eyes) were recruited. The sex ratio was 2. The average age was 15 ± 9 years. Initially, pruritus was the main symptom (96.7%). After an average follow-up of five years, VA was usefulin all patients (100%) and TELCstage 2 was the most frequent stage (60%). The mean number of recurrences was three. Postpubertal patients had anatomical improvement in 56.7% of cases and worsening in 10%of cases. Conclusion. Our study confirms the overall postpubertal improvement ofTELC, except some serious forms with poor prognosis ofvisual function


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Conjunctivitis, Allergic , Conjunctivitis , Endemic Diseases , Diagnosis, Differential , Epidemiology
2.
Arq. Asma, Alerg. Imunol ; 6(1): 4-48, jan.mar.2022. ilus
Article in English, Portuguese | LILACS | ID: biblio-1400091

ABSTRACT

A alergia ocular, também conhecida como conjuntivite alérgica (CA), é uma reação de hipersensibilidade mediada por imunoglobulina E (IgE) do olho desencadeada por aeroalérgenos, principalmente ácaros da poeira doméstica e pólen de gramíneas. Os sintomas geralmente consistem em prurido ocular ou periocular, lacrimejamento e olhos vermelhos que podem estar presentes durante todo o ano ou sazonalmente. A alergia ocular tem frequência elevada, é subdiagnosticada e pode ser debilitante para o paciente. É potencialmente danosa para a visão, nos casos em que ocasiona cicatrização corneana grave, e na maioria dos pacientes associa-se a outros quadros alérgicos, principalmente rinite, asma e dermatite atópica. É classificada em conjuntivite alérgica perene, conjuntivite alérgica sazonal, ceratoconjuntivite atópica e ceratoconjuntivite vernal. O diagnóstico procura evidenciar o agente etiológico e a confirmação se dá pela realização do teste de provocação conjuntival. O tratamento baseia-se em evitar o contato com os desencadeantes, lubrificação, anti-histamínicos tópicos, estabilizadores de mastócitos, imunossupressores e imunoterapia específica com o objetivo de obter o controle e prevenir as complicações da doença.


Ocular allergy, also known as allergic conjunctivitis, is an immunoglobulin E-mediated hypersensitivity reaction of the eye triggered by airborne allergens, primarily house dust mites and grass pollen. Symptoms usually consist of ocular or periocular itching, watery eyes, and red eyes that may be present year-round or seasonally. Ocular allergy has a high frequency, is underdiagnosed, and can be debilitating for the patient. It is potentially harmful to vision in cases of severe corneal scarring, and in most patients, it is associated with other allergic conditions, especially rhinitis, asthma, and atopic dermatitis. It is classified as perennial allergic conjunctivitis, seasonal allergic conjunctivitis, atopic keratoconjunctivitis, and vernal keratoconjunctivitis. Diagnosis seeks to identify the etiologic agent, and confirmation is given by conjunctival provocation testing. Treatment is based on avoiding contact with triggers, lubrication, topical antihistamines, mast cell stabilizers, immunosuppressants, and specific immunotherapy with the aim of achieving control and preventing disease complications.


Subject(s)
Humans , Therapeutics , Conjunctivitis, Allergic , Diagnosis , Keratoconjunctivitis , Patients , Plants, Medicinal , Pruritus , Psychotherapy , Asthma , Signs and Symptoms , Societies, Medical , Vision, Ocular , Climate Change , Conjunctivitis, Allergic/complications , Conjunctivitis, Allergic/epidemiology , Complementary Therapies , Immunoglobulin E , Serologic Tests , Skin Tests , Allergens , Rhinitis , Rhinitis, Allergic, Seasonal , Probiotics , Acupuncture , Pyroglyphidae , Dermatitis, Atopic , Environmental Pollution , Allergy and Immunology , Antibodies, Monoclonal, Humanized , Omalizumab , Mast Cell Stabilizers , Histamine Antagonists , Hypersensitivity , Immunosuppressive Agents , Immunotherapy , Medicine, Ayurvedic , Mites
3.
Research Journal of Heath Sciences ; 10(2): 131-138, 2022.
Article in English | AIM | ID: biblio-1370790

ABSTRACT

Background ­ University, a subset of the general population, will expectedly have common ocular problems as prevalent in the population. Knowing these problems as done through screening and health education during WSD activities in 2017 thus raise awareness for their prevention. This study was aimed at determining the types of eye defects in a university community. Methodology ­ A descriptive cross-sectional survey utilizing purposive serial selection to examine inhabitants of a university community. Socio-demographic information and detailed ocular examinations were carried out. Data analysis using SPSS Version 20 and cross tabulations with statistical significance derived using paired sample t-test at p values < 0.05 were done. Results ­ With n=140, 79(56.4 %) were males. Mean age was 26.7 + 11.5years. Majority were staffs (77.1%) with 62.1% having tertiary education. Normal vision was reported in (92.9%), while 5.7% had visual impairment with 1.4% uniocular blindness. Common ocular findings were allergic conjunctivitis (12.9%), glaucoma suspects (10.0%), Pterygium (3.6%), glaucoma/corneal opacity (2.1% respectively), and optic atrophy (1.4%). Conclusion ­Disorders seen were mostly avoidable. Incorporating eye health services into University Healthcare will control their occurrence allowing optimal job performance.


Subject(s)
Vision Disorders , Mass Screening , Disease Prevention , Eye Diseases , Universities , Conjunctivitis, Allergic , Glaucoma
4.
Arq. Asma, Alerg. Imunol ; 5(3): 295-297, jul.set.2021. ilus
Article in English | LILACS | ID: biblio-1399397

ABSTRACT

Cyclamen is a plant belonging to the Primulaceae family, widely used as an indoor ornamental flowering plant. Occupational allergy to cyclamen has been occasionally described in the current literature. The authors intend to report the case and diagnostic approach of a suspected occupational cyclamen allergy.


O ciclame é uma planta pertencente à família Primulaceae, amplamente utilizada como planta ornamental de interior. A alergia ocupacional ao ciclame raramente foi descrita na literatura. Os autores pretendem descrever um caso e abordagem diagnóstica de uma suspeita de alergia ocupacional ao ciclame.


Subject(s)
Humans , Female , Middle Aged , Conjunctivitis, Allergic , Cyclamen , Hypersensitivity , Plants , Primulaceae
5.
Rev. bras. oftalmol ; 80(4): e0016, 2021. tab
Article in Portuguese | LILACS | ID: biblio-1288633

ABSTRACT

RESUMO Objetivo: Avaliar a possibilidade de alterações precoces sugestivas de ectasia detectáveis no Pentacam em casos sutis de alergia ocular em crianças. Métodos: Análise retrospectiva de 49 prontuários, com paciente de ambos os sexos e idades entre 3 e 14 anos. Do total de crianças estudadas, 31 apresentavam alergia ocular grau 1, e 18 não apresentavam qualquer sinal ou sintoma de alergia ocular, servindo como controles. Avaliaram-se diversos índices do Pentacam. Resultados: Houve associação estatisticamente significativa nas variáveis "Df - variação do mapa da elevação anterior da córnea" e "Pentacam combinado", que podem estar relacionadas com a detecção precoce de ectasia corneana nesses pacientes. Conclusão: Houve relação causal entre a prevalência da alergia ocular e alterações tomográficas na córnea, sugestivas de ceratocone em alguns pacientes provavelmente suscetíveis, podendo ser considerado um fator de risco para essa complicação.


ABSTRACT Objective: To assess if early alterations detected by Pentacam in children suffering from mild ocular allergy are suggestive of ectasia. Methods: A retrospective analysis of 49 medical records of patients of both sexes, aged between 3 and 14 years was performed. In this sample, 31 children suffered from grade I ocular allergy, and 18 presented no signs or symptoms of ocular allergy and comprised the control group. Several Pentacam indexes were evaluated. Results: A statistically significant association was found in the variables "Df - variation of the anterior corneal elevation map" and "combined Pentacam", which can be related to the early detection of corneal ectasia in these patients. Conclusion: There was a causal relation between prevalence of ocular allergy and tomographic alterations on the cornea, suggestive of keratoconus in some probably susceptible patients, which may be considered a risk factor for this complication.


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Conjunctivitis, Allergic/complications , Conjunctivitis, Allergic/etiology , Keratoconus/diagnosis , Keratoconus/etiology , Keratoconus/epidemiology , Retrospective Studies , Corneal Topography , Diagnostic Techniques, Ophthalmological
7.
Arq. bras. oftalmol ; 82(2): 119-123, Mar.-Apr. 2019. graf
Article in English | LILACS | ID: biblio-989390

ABSTRACT

ABSTRACT Purpose: To assess the compliance, efficacy, and safety of the long-term use of topical tacrolimus for the clinical management of vernal keratoconjunctivitis. Methods: The medical records of patients with vernal keratoconjunctivitis undergoing long-term treatment with 0.03% topical tacrolimus were retrospectively reviewed. The duration of tacrolimus use and the causes for drug discontinuation were used to assess treatment compliance. To assess drug efficacy, the need for and the number of times that topical corticosteroids were used to control symptoms were registered. Side effects related to tacrolimus use were monitored to determine drug safety. Results: The study cohort consisted of 21 patients who met the eligibility criteria. The mean duration of tacrolimus use was 41.3 ± 18.5 months. Fourteen patients (66.7%) continuously used tacrolimus, and three (14.3%) discontinued treatment following complete remission. Four patients (19%) did not use tacrolimus as prescribed or interrupted tacrolimus use on their own: two (9.5%) because of discomfort upon application and two (9.5%) because of the lack of improvement. Ten patients (47.6%) maintained disease control without the use of corticosteroids, whereas 11 (52.4%) required an average of 2.70 ± 1.35 corticosteroid cycles to control symptoms. The only reported side effect was discomfort upon application. Conclusions: Despite the small sample size and study design limitations, these results support the long-term use of topical tacrolimus as an effective and safe option for the treatment of vernal keratoconjunctivitis, with good compliance of patients to the treatment.


RESUMO Objetivo: Avaliar a aderência, a eficácia e segurança do uso prolongado de tacrolimus tópico no controle clínico da ceratoconjuntivite vernal. Métodos: Um estudo retrospectivo foi desenvolvido através da análise de prontuários de pacientes com ceratoconjuntivite vernal em tratamento prolongado com tacrolimus tópico 0,03%. A duração do tempo de uso do ta­crolimus e as causas de descontinuação da medicação foram usadas para avaliar a adesão ao tratamento. Para avaliar a eficácia da droga, a necessidade e o número de vezes em que corticoides tópicos foram utilizados para controlar os sintomas foram registrados. Os efeitos colaterais relacionados ao uso do tacrolimus foram monitorados para determinar a segurança da droga. Resultados: Vinte e um pacientes preencheram os critérios de eleição e foram incluídos no estudo. A duração média do uso de tacrolimus foi de 41,3 ± 18,5 meses. Quatorze pacientes (66,7%) usaram continuamente o tacrolimus e 3 (14,3%) descontinuaram o tratamento após a remissão completa. Quatro pacientes (19%) não usaram o tacrolimus conforme prescrito ou interromperam o uso da droga isoladamente: 2 (9,5%) por desconforto na aplicação e 2 (9,5%) pela falta de melhora. Dez pacientes (47,6%) mantiveram a doença sob controle sem o uso de corticoides, enquanto 11 (52,4%) necessitaram em média 2,70 ± 1,35 ciclos corticoides para controle dos sintomas. O único efeito adverso relatado foi desconforto na aplicação. Conclusões: Apesar do pequeno tamanho da amostra e das limitações do desenho do estudo, esses resultados suportam o uso prolongado do tacrolimus tópico como opção eficaz e segura para o tratamento da ceratoconjuntivite vernal, com boa adesão dos pacientes ao tratamento.


Subject(s)
Humans , Male , Female , Child , Adolescent , Young Adult , Conjunctivitis, Allergic/drug therapy , Tacrolimus/administration & dosage , Administration, Ophthalmic , Immunosuppressive Agents/administration & dosage , Ointments/administration & dosage , Time Factors , Reproducibility of Results , Retrospective Studies , Treatment Outcome , Adrenal Cortex Hormones/therapeutic use , Medication Adherence
8.
Journal of the Korean Ophthalmological Society ; : 190-194, 2019.
Article in Korean | WPRIM | ID: wpr-738596

ABSTRACT

PURPOSE: We report a case of toxic keratoconjunctivitis resulting from the self-application of human breast milk as a traditional folk remedy for allergic conjunctivitis. CASE SUMMARY: An 82-year-old woman presented with pain and conjunctival hyperemia in the right eye that had been worsening for three days. Two months previously, she was treated with antiallergic eye drops for allergic conjunctivitis at another eye clinic. However, the symptoms did not improve. She applied her daughter-in-law's breast milk into her right eye as a folk remedy for three days. The pain and conjunctival hyperemia worsened. At the initial visit, her corrected visual acuity was 0.3 in the right eye. Slit lamp examination demonstrated conjunctival hyperemia, punctate epithelial erosion at the central cornea, corneal keratic precipitates and white-colored deposits in the peripheral cornea combined with irregularly shaped small nodules. There was no anterior chamber inflammation. There was no medical history of rheumatoid arthritis or tuberculosis. Blood tests for serum and other infectious and inflammatory levels for infection and inflammatory markers were performed followed by application of topical steroids and antibiotics with artificial tears. After 3 weeks of treatment, conjunctival hyperemia and corneal deposits had almost resolved and best-corrected visual acuity improved to 1.0. CONCLUSIONS: The self-application of human breast milk may cause toxic keratoconjunctivitis. Therefore, efforts should be made, actively, to inform and educate the elderly in rural areas not to use human breast milk as a folk remedy.


Subject(s)
Aged , Aged, 80 and over , Female , Humans , Anterior Chamber , Anti-Bacterial Agents , Arthritis, Rheumatoid , Breast , Conjunctivitis, Allergic , Cornea , Hematologic Tests , Hyperemia , Inflammation , Keratoconjunctivitis , Lubricant Eye Drops , Medicine, Traditional , Milk, Human , Ophthalmic Solutions , Slit Lamp , Steroids , Tuberculosis , Visual Acuity
9.
S. Afr. fam. pract. (2004, Online) ; 61(3): 46-50, 2019. tab
Article in English | AIM | ID: biblio-1270088

ABSTRACT

Conjunctivitis is a common eye condition involving inflammation and in some instances infection of the conjunctiva. In the majority of cases it is caused by adenoviruses and, to a lesser extent, bacteria. Conjunctivitis can also occur secondary to Chlamydial and Gonococcal infections and new-born infants can acquire it during the birthing process from infected mothers. Herpes simplex and Herpes zoster are the infective organisms also responsible for conjunctivitis while seasonal pollens are usually the cause for allergic conjunctivitis. Common symptoms and signs are redness, tearing, oedema of the eyelids, sensation of a foreign body and it may be accompanied by itching. Most often a purulent discharge and adherence of eyelids at awakening are indicators of a bacterial infection. Most of the uncomplicated acute cases are self-limiting. There is however a challenge in distinguishing between the various types of conjunctivitis due to the similarity in the symptoms and due to a lack of tests and prediction algorithms, thus antibiotic therapy is often incorrectly initiated. Treatment of acute uncomplicated conjunctivitis caused by adenoviruses and bacteria is mostly symptomatic. Topical eye drops and ointments are preferred to oral agents in the treatment of more severe bacterial and allergic conjunctivitis while oral agents are used in the treatment of conjunctivitis caused by Herpes simplex, Herpes zoster, Chlamydia trachomatis and Neisseria gonorrhoeae


Subject(s)
Conjunctivitis , Conjunctivitis, Allergic , Conjunctivitis, Bacterial , Conjunctivitis, Viral , South Africa
10.
S. Afr. fam. pract. (2004, Online) ; 61(4): 6-10, 2019. tab
Article in English | AIM | ID: biblio-1270099

ABSTRACT

Conjunctivitis is a common condition characterised by inflammation of the conjunctiva and is the most likely diagnosis in a patient with a red eye and discharge. Acute conjunctivitis is usually a self-limiting condition or one that is easily treated with topical ophthalmic preparations in most cases. Viral conjunctivitis is the most common cause of conjunctivitis followed by bacterial conjunctivitis. Purulent discharge and adherence of the eyelids upon awakening are strong indicators of bacterial conjunctivitis, however other similarities in presentation of conjunctivitis often leads to misdiagnoses. Acute viral conjunctivitis is most commonly caused by adenoviruses and allergic conjunctivitis is usually caused by seasonal pollens. Acute viral conjunctivitis is treated symptomatically while the use of topical antibiotics are useful in limiting the duration of conjunctivitis with a bacterial aetiology. Allergic conjunctivitis is also treated symptomatically with topical antihistamine/mast cell stabiliser preparations. Conjunctivitis secondary to sexually transmitted diseases such as chlamydia or gonorrhoea require systemic antimicrobials in addition to topical treatment


Subject(s)
Conjunctivitis, Allergic , Conjunctivitis, Bacterial , Conjunctivitis, Viral , South Africa
11.
Rev. méd. Chile ; 146(9): 994-1000, set. 2018. tab
Article in Spanish | LILACS | ID: biblio-978789

ABSTRACT

Background: Allergic rhinoconjunctivitis (ARC) has a prevalence of 30% in industrialized countries. For an accurate diagnosis and treatment, it is crucial to identify the causative aeroallergen. Aim: To evaluate aeroallergen sensitization in adults with ARC in the city of Temuco, Chile. Patients and Methods: A skin test against the main aeroallergens present in Temuco was carried out in patients aged 15 to 64 years with ARC diagnosed by medical examination and the Score For Allergic Rhinitis. Results: At least one aeroallergen sensitization was present in 234 (62.4%) out of 375 patients. Pollen-sensitized patients were positive mainly for Grasses (44.4%), Plantago (27.8%), Cynodon (26.1%), Sorrel (23.5%), Birch (14.9%), Nothofagus obliqua (13.3%) and Alder (11.1%). Dust mites were the most common non-pollinic sensitizing aeroallergens, including Dermatophagoides pteronyssinus (70.1%) and Dermatophagoides farinae (62.8%). Conclusions: According to our results, skin tests in the city of Temuco should include at least dust mites, pollens of Grasses, Plantago, Cynodon, Sorrel, Birch, Nothofagus obliqua and Alder, because these allergens account for 93% of ARC cases in this city.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Young Adult , Conjunctivitis, Allergic/etiology , Skin Tests/methods , Allergens/classification , Rhinitis, Allergic/etiology , Conjunctivitis, Allergic/diagnosis , Conjunctivitis, Allergic/epidemiology , Chile/epidemiology , Cross-Sectional Studies , Surveys and Questionnaires , Sensitivity and Specificity , Rhinitis, Allergic/diagnosis , Rhinitis, Allergic/epidemiology
12.
Arq. Asma, Alerg. Imunol ; 2(3): 357-363, jul.set.2018. ilus
Article in Portuguese | LILACS | ID: biblio-1380935

ABSTRACT

Introdução: A conjuntivite alérgica (CA) é uma doença inflamatória da conjuntiva ocular causada principalmente por mecanismo IgE-mediado. É o tipo mais comum de alergia ocular. O presente estudo teve por objetivo identificar fatores associados à CA de diferentes intensidades em pacientes acompanhados em ambulatório pediátrico especializado em doenças alérgicas, visando, assim, facilitar o diagnóstico, a terapêutica e a profilaxia dessa morbidade. Métodos: Este estudo retrospectivo analisou prontuários de pacientes (n = 120) com diagnóstico clínico de CA acompanhados em ambulatório especializado por pelo menos um ano. O diagnóstico de CA foi realizado por oftalmologista, e, segundo os medicamentos utilizados, os pacientes foram classificados em CA grave (corticosteroide oral, imunossupressor tópico ou sistêmico e/ou com lesão corneana) ou não grave. Todos foram submetidos a testes cutâneos de leitura imediata com bateria padronizada de aeroalérgenos. Quinze pacientes foram escolhidos aleatoriamente e submetidos à pesquisa de IgE sérica específica (ImmunoCap-ISAC; Thermo Scientific). Resultados: Formas graves de CA ocorreram em 36/120 pacientes, com predomínio de sexo masculino (86,1%), presença de história familiar de CA e uso de lubrificantes e de imunossupressores tópicos. Não houve diferenças quanto à sensibilização a aeroalérgenos, mas entre as formas graves predominou a polissensibilização. Houve predomínio de sensibilização aos ácaros da poeira domiciliar. Conclusão: Nosso estudo-piloto mostrou que formas graves de CA foram associadas ao sexo masculino, ter história familiar de conjuntivite alérgica, e ser sensibilizado a ácaros da poeira domiciliar. Estudos adicionais são necessários para melhor caracterizar os possíveis fatores de risco associados à maior gravidade da CA.


Introduction: Allergic conjunctivitis (AC) is an inflammatory disease of the ocular conjunctiva mainly caused by IgE-mediated mechanism. It is the most common type of ocular allergy. The present study aimed to identify factors associated with AC of different degrees of severity in patients followed in a pediatric outpatient clinic specializing in allergic diseases, in order to facilitate the diagnosis, therapy and prophylaxis of this morbidity. Methods: This retrospective study assessed medical records of patients (n = 120) with clinical diagnosis of AC followed at a specialized outpatient clinic for at least one year. The diagnosis of AC was performed by an ophthalmologist and, according to the medications used, the patients were classified as having severe AC (oral corticosteroid, topical or systemic immunosuppressive drug and/or corneal injury) or non-severe AC. All patients underwent skin prick tests with a standardized battery of aeroallergens. Fifteen patients were randomly selected to undergo serum specific IgE screening (ImmunoCap-ISAC; Thermo Scientific). Results: Severe forms of AC occurred in 36/120 patients with predominance of male sex (86.1%), presence of family history of AC, and use of lubricants and topical immunosuppressive drugs. There were no differences in sensitization to aeroallergens, but polysensitization prevailed among the severe forms. There was a predominance of sensitization to house dust mites. Conclusion: Our pilot study showed that severe forms of AC were associated with being male, having a family history of allergic conjunctivitis and being sensitized to house dust mites. Additional studies are needed to better characterize possible risk factors associated with increased AC severity.


Subject(s)
Humans , Infant , Child, Preschool , Child , Adolescent , Conjunctivitis, Allergic , Risk Factors , Keratoconjunctivitis , Therapeutics , Wounds and Injuries , Immunoglobulin E , Skin Tests , Medical Records , Retrospective Studies , Adrenal Cortex Hormones , Conjunctiva , Serum , Diagnosis , Lubricants , Corneal Injuries , Ophthalmologists , Mites
13.
Archives of Plastic Surgery ; : 222-228, 2018.
Article in English | WPRIM | ID: wpr-714454

ABSTRACT

BACKGROUND: The most common surgical treatment for paralytic lagophthalmos is the placement of a weight implant in the upper eyelid; however, this technique confers the risks of implant visibility, implant extrusion, and entropion. In this study, we present a new technique of placing platinum weight implants between the levator aponeurosis and inner septum to decrease such complications. METHODS: A total of 37 patients with paralytic lagophthalmos were treated between March 2014 and January 2017 with platinum weight placement (mean follow-up, 520.1 days). After dissecting through the orbicularis oculi muscle, the tarsal plate and levator aponeurosis were exposed. The platinum weights (1.0–1.4 g) were fixed to the upper margin of the tarsal plate and placed underneath the orbital septum. RESULTS: Five patients could partially close their eye after surgery. The average distance between the upper eyelid and the lower eyelid when the eyes were closed was 1.12 mm. The rest of the patients were able to close their eye completely. Three patients patient developed allergic conjunctivitis after platinum weight insertion, which was managed with medication. None of the patients complained of discomfort in the upper eyelid after surgery. Visibility or extrusion of the implant were observed in three patients. CONCLUSIONS: Postseptal weight placement is a safe and reproducible method in both primary and secondary upper eyelid surgery for patients with paralytic lagophthalmos. It is a feasible method for preventing implant visibility, implant exposure, and entropion. Moreover, platinum is a better implant material than gold because of its smaller size and greater thinness.


Subject(s)
Humans , Conjunctivitis, Allergic , Entropion , Eyelid Diseases , Eyelids , Facial Paralysis , Follow-Up Studies , Methods , Orbit , Platinum , Prostheses and Implants , Thinness , Weights and Measures
14.
J. bras. pneumol ; 43(5): 368-372, Sept.-Oct. 2017. tab
Article in English | LILACS | ID: biblio-893869

ABSTRACT

ABSTRACT Objective: To assess the prevalences of asthma, allergic rhinitis, and allergic rhinoconjunctivitis in adolescents in the city of Belo Horizonte, Brazil, in 2012 by administering the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire, as well as to compare the observed prevalences with those found in studies performed 10 years earlier and employing the same methodology used here. Methods: This was a cross-sectional study conducted between May and December of 2012 and involving adolescents in the 13- to 14-year age bracket. Participants were randomly selected from among adolescents studying at public schools in Belo Horizonte and completed the ISAAC questionnaire. Proportions were calculated in order to assess the prevalences of asthma, allergic rhinitis, and allergic rhinoconjunctivitis in the sample as a whole, and the chi-square goodness-of-fit test was used in order to compare the prevalences observed in 2012 with those found in 2002. Results: The prevalences of symptoms of asthma, allergic rhinitis, and allergic rhinoconjunctivitis in 2012 were 19.8%, 35.3%, and 16.3%, respectively, being significantly higher than those found in 2002 (asthma, p = 0.006; allergic rhinitis, p < 0.01; and allergic rhinoconjunctivitis, p = 0.002). Conclusions: The prevalences of asthma, allergic rhinitis, and allergic rhinoconjunctivitis among adolescents in 2012 were found to be high, having increased in comparison with those found 10 years earlier, despite efforts in prevention, diagnosis, and treatment.


RESUMO Objetivo: Avaliar as prevalências de asma, rinite alérgica e rinoconjuntivite alérgica em adolescentes da cidade de Belo Horizonte (MG) através do questionário do International Study of Asthma and Allergies in Childhood no ano de 2012, bem como compará-las com aquelas obtidas em estudos realizados 10 anos antes empregando a mesma metodologia. Métodos: Estudo transversal realizado com estudantes de 13-14 anos de idade de escolas públicas localizadas no município, selecionados de forma aleatória simples, entre maio e dezembro de 2012, com a utilização do questionário. Foram realizados cálculos das diferenças de proporções para a análise das prevalências de asma, rinite alérgica e rinoconjuntivite alérgica na amostra geral, e o teste de qui-quadrado de adesão foi utilizado para a comparação das prevalências de 2012 e 2002. Resultados: As prevalências de sintomas de asma, rinite alérgica e rinoconjuntivite alérgica em 2012 foram de 19,8%, 35,3% e 16,3%, respectivamente. Houve aumentos significativos dessas prevalências em relação ao ano de 2002 (asma, p = 0,006; rinite alérgica, p < 0.01; e rinoconjuntivite alérgica, p = 0.002). Conclusões: Foram evidenciados elevadas taxas de asma, rinite alérgica e rinoconjuntivite alérgica entre os adolescentes estudados e aumentos dessas prevalências no intervalo de 10 anos, apesar dos esforços no âmbito da prevenção, diagnóstico e tratamento dessas doenças.


Subject(s)
Humans , Male , Female , Adolescent , Asthma/epidemiology , Conjunctivitis, Allergic/epidemiology , Rhinitis, Allergic/epidemiology , Asthma/diagnosis , Brazil/epidemiology , Cross-Sectional Studies , Prevalence , Schools/statistics & numerical data , Surveys and Questionnaires
15.
Arq. bras. oftalmol ; 80(4): 211-214, July-Aug. 2017. tab, graf
Article in English | LILACS | ID: biblio-888123

ABSTRACT

ABSTRACT Purpose: Administration of eye drops containing antihistamines or sodium cromoglycate and its derivatives for the treatment of allergic keratoconjunctivitis is often insufficient and usually requires the addition of corticosteroids. However, the risk of complications, such as glaucoma and cataract, limits the use of corticosteroids to short courses, resulting in inadequate long-term treatment response. Immunosuppressive drugs have been considered as a valid alternative to steroids for atopic keratoconjunctivitis and vernal keratoconjunctivitis. This study aimed to evaluate the use of topical tacrolimus (TCL) in improving the clinical signs of severe allergic keratoconjuctivitis in children. Methods: Patients with severe allergic keratoconjunctivitis associated with corneal epitheliopathy, gelatinous limbal infiltrates, and/or papillary reaction, along with a history of recurrences and resistance to conventional topical anti-allergy agents, were included in this open clinical trial. Patients were treated with 0.03% TCL ointment for ocular use. A severity score ranging from 0 to 9, with 9 being the highest and 0 being the lowest, was assigned based on signs observed on biomicroscopy prior to and following TCL treatment. Results: Analyses included 66 eyes of 33 patients. After a mean follow-up period of 13 months (range, 12-29 months), TCL treatment significantly decreased the mean symptom score severity for the right (from 5.56 ± 1.18 to 2.76 ± 1.5; p<0.001) and left (from 5.94 ± 1.16 to 2.86 ± 1.64; p<0.001). Conclusion: Topical TCL was effective and significantly improved the clinical signs of allergic keratoconjuctivitis in children. Thus, it is a potential new option for severe and challenging cases of ocular allergy.


RESUMO Objetivos: O tratamento da ceratoconjuntivite alérgica baseado em colírios que contenham anti-histamínicos ou cromoglicato de sódio e seus derivados geralmente são insuficientes. A adição de corticosteróides geralmente é mandatória. No entanto, o risco de complicações como glaucoma e catarata limita o uso dos corticosteróides em curtos períodos de tratamento resultando em respostas inadequadas a longo prazo. Drogas imunossupressoras vem sendo consideradas como uma opção terapêutica alternativa válida para as ceratoconjuntivite atópica (AKC) e ceratoconjuntivite vernal (VKC). Este trabalho tem como objetivo avaliar a melhora nos sinais clínicos durante o uso de tacrolimus (TCL) tópico em crianças com ceratoconjuntivites alérgicas. Métodos: Pacientes com ceratoconjuntivite alérgica severa associada a ceratites, infiltrados limbares gelatinosos e/ou papilas gigantes, com história de recorrências e resistência ao tratamento anti-alérgico tópico convencional foram incluídos neste estudo. Os pacientes foram tratados com TCL 0,03% pomada tópica para uso ocular. Um escore variando de 0 a 9 foi atribuído para os sinais observados na biomicroscopia antes e depois do tratamento. Quanto maiores os escores, mais severos eram os sinais. Resultados: Foram estudados 66 olhos de 33 pacientes. Antes do tratamento a média do escore para o olho direito foi 5,56 ± 1,18 e para o olho esquerdo 5,94 ± 1,16. Após o tratamento com TCL a média do escore para o olho direito foi 2,76 ± 1,5 e para o olho esquerdo 2,86 ± 1,64 (p<0.001 para os dois olhos). O tempo de seguimento médio foi de 13 meses (12-29 meses). Conclusão: O presente estudo sugere que o TCL tópico foi efetivo e demonstrou resultado satisfatório, com melhora nos sinais clínicos na ceratoconjuntivite alérgica em crianças, constituindo uma nova opção para o tratamento de casos severos de alergia ocular.


Subject(s)
Humans , Male , Female , Child , Adolescent , Conjunctivitis, Allergic/drug therapy , Tacrolimus/administration & dosage , Immunosuppressive Agents/administration & dosage , Keratoconjunctivitis/drug therapy , Severity of Illness Index , Prospective Studies , Follow-Up Studies , Administration, Topical , Treatment Outcome , Cyclosporine/administration & dosage , Microscopy/methods
16.
Arq. bras. oftalmol ; 80(3): 186-188, May-June 2017. tab, graf
Article in English | LILACS | ID: biblio-888116

ABSTRACT

ABSTRACT Purpose: To evaluate the use of supratarsal injection of triamcinolone acetonide in severe vernal keratoconjunctivitis (VKC) in children. Methods: Patients included in this open clinical trial were those with severe VKC-associated with keratitis, gelatinous limbal infiltrates, and/or giant papillae, with a history of recurrence and resistance to conventional topical antiallergic agents. Patients were treated with a supratarsal injection of 20 mg triamcinolone acetonide. Results: Analysis included 27 injections in 23 eyes of 17 patients with severe allergic keratoconjunctivitis. Mean age was 12.3 (range: 7-19) years. Mean follow-up time was 39.3 months (SD=19.21). In the 17 patients, the disease was successfully controlled for an average of 3.6 months (range: 1-16), during which allergy symptoms and signs were significantly improved, with complete resolution of lid edema and conjunctival chemosis, significant decline of pannus and keratitis, and reduction of giant papillae size. Conclusion: Treatment of severe, acute VKC in children with supratarsal injection of 20 mg triamcinolone acetonide showed satisfactory results and was well tolerated by patients; it may therefore constitute a safe option for severe and challenging cases. While full disease remission was not achieved, a significant improvement was found in ocular allergy symptoms and signs, with a reduction in the frequency of acute recurrences.


RESUMO Objetivo: Avaliar o uso da injeção supratarsal de triancinolona na ceratocon junti vite primaveril grave (VKC) em crianças. Métodos: Pacientes com VKC grave associada à ceratite, limbo gelatinoso e/ou papilas gigantes, com história de recidivas e resistência a agentes antialérgicos tópicos convencionais foram incluídos neste ensaio clínico. Os pacientes foram tratados com injeção de 20 mg de acetato de triancinolona supratarsal. Resultados: A análise incluiu 23 olhos de 17 pacientes com ceratoconjuntivite alérgica grave. A idade média foi de 12,3 com intervalo de 7-19 anos. O tempo médio de acompanhamento foi de 39,3 meses (DP 19,21). Dos 17 pacientes, a doença foi controlada com sucesso por uma média de 3,6 meses (intervalo 1-16) em que os sinais e sintomas foram significativamente melhorados com resolução completa do edema palpebral e quemose conjuntival, redução significativa de pannus, ceratite e redução do tamanho das papilas gigantes. Conclusão: O tratamento da VKC grave em crianças com injeção supratarsal de 20 mg de acetato de triancinolona mostrou resultados satisfatórios, sendo bem tolerada pelas crianças às quais foram submetidas, podendo constituir uma opção segura para casos graves e difíceis de VKC. Uma melhora significativa foi encontrada nos sinais e sintomas alérgicos oculares, com diminuição da frequência de recidivas agudas, no entanto sem se mostrar efetiva para a completa remissão da doença.


Subject(s)
Humans , Male , Female , Child , Adolescent , Young Adult , Conjunctivitis, Allergic/drug therapy , Triamcinolone Acetonide/administration & dosage , Injections, Intraocular , Glucocorticoids/administration & dosage , Time Factors , Prospective Studies , Reproducibility of Results , Treatment Outcome , Age of Onset , Eyelids/drug effects , Administration, Ophthalmic , Medical Illustration
17.
Arq. bras. oftalmol ; 80(3): 154-158, May-June 2017. tab, graf
Article in English | LILACS | ID: biblio-888114

ABSTRACT

ABSTRACT Purpose: To assess the efficacy of monotherapy using tacrolimus eye drops versus sodium cromoglycate for the treatment of vernal keratoconjunctivitis (VKC). Methods: Randomized double-masked controlled trial comparing the efficacy of tacrolimus 0.03% eye drops t.i.d. (Group 1) with sodium cromoglycate 4% eye drops t.i.d. (Group 2) for the symptomatic control of VKC at days 0, 15, 30, 45, and 90 of follow-up. Visual acuity, intraocular pressure, and other complications were evaluated to assess safety and side effects. Results: In total, 16 patients were included, with 8 enrolled in each group. Two patients from Group 2 were excluded from the analysis at days 45 and 90 because of corticosteroid use. Most patients were male (81.8%) and presented with limbal VKC (56.3%). There were statistically significant differences in favor of tacrolimus in the following severity scores: itching at day 90 (p=0.001); foreign body sensation at day 15 (p=0.042); photophobia at day 30 (p=0.041); keratitis at day 30 (p=0.048); and limbal activity at days 15 (p=0.011), 30 (p=0.007), and 45 (p=0.015). No relevant adverse effects were reported, except for a burning sensation with tacrolimus, though this did not compromise treatment compliance. Conclusion: Treatment with tacrolimus was superior to sodium cromoglycate when comparing severity scores for symptoms of itching, foreign body sensation, and photophobia, as well as for signs of limbal inflammatory activity and keratitis.


RESUMO Objetivo: Demonstrar a eficácia do colírio de tacrolimus 0,03% como único agente antialérgico versus o colírio de cromoglicato de sódio 4% no tratamento de ceratoconjuntivite primaveril (CCP). Métodos: Ensaio clínico randomizado duplo-mascarado comparando a eficácia do colírio de tacrolimus 0,03% 3 vezes ao dia, versus o colírio de cromoglicato 4% 3 vezes ao dia, no controle dos sintomas e sinais de pacientes com o diagnóstico de ceratoconjuntivite primaveril, durante o período de 3 meses, com avaliações nos dias 0, 15, 30, 45 e 90. Acuidade visual, pressão intraocular e outras possíveis complicações foram avaliadas para determinar segurança e efeitos adversos. Resultados: Dezesseis pacientes foram incluídos no estudo, sendo que oito fizeram uso de colírio de tacrolimus 0,03% (Grupo 1) e oito fizeram uso de colírio de cromoglicato de sódio 4% (Grupo 2). Dois pacientes do Grupo 2 foram excluídos da análise dos dias 45 e 90, devido à necessidade de utilização de corticosteroide tópico. A maioria dos pacientes era do sexo masculino (81,8%) e 56,3% apresentavam a doença em sua forma limbar. Houve diferença estatisticamente significativa entre os Grupos 1 e 2 em relação à graduação de severidade para os sintomas de prurido no dia 90 (p=0,001), sensação de corpo estranho no dia 15 (p=0,042), fotofobia no dia 30 (p=0,041) e para os sinais de atividade inflamatória limbar nos dias 15 (p=0,011), 30 (p=0,007) e 45 (p=0,015), e ceratite no dia 30 (p=0,048). Nenhum efeito adverso relevante foi notado, exceto queixa de queimação ocular quando da instilação de tacrolimus, o que não comprometeu à adesão ao tratamento. Conclusão: O colírio de tacrolimus 0,03% foi superior ao colírio de cromoglicato de sódio 4% comparando a graduação de severidade para os sintomas de prurido, sensação de corpo estranho e fotofobia, assim como para os sinais de atividade inflamatória limbar e ceratite, em determinados períodos de tempo durante o seguimento.


Subject(s)
Humans , Male , Female , Child , Adolescent , Conjunctivitis, Allergic/drug therapy , Tacrolimus/therapeutic use , Immunosuppressive Agents/therapeutic use , Ophthalmic Solutions/therapeutic use , Time Factors , Severity of Illness Index , Conjunctivitis, Allergic/pathology , Visual Acuity , Double-Blind Method , Treatment Outcome , Cromolyn Sodium/therapeutic use , Statistics, Nonparametric
19.
Asia Pacific Allergy ; (4): 138-147, 2017.
Article in English | WPRIM | ID: wpr-750109

ABSTRACT

BACKGROUND: Pollen allergens are one of the main contributors to the development and/or aggravation of allergic rhinitis, allergic conjunctivitis, and asthma. OBJECTIVE: An examination of the airborne pollen in residential areas should be conducted to aid the diagnosis and treatment of allergic diseases. METHODS: Airborne pollen samples were collected from 2 sites in Incheon and 2 in Seoul from 2015 to 2016. RESULTS: The highest monthly concentration of airborne pollen was observed in May and September each year. Pollen from 32 families and 50 genera was identified over the 2 years; of these, Pinus spp. showed the highest pollen concentration (41.6%), followed by Quercus spp. (25.3%), and Humulus spp. (15.3%), the latter of which had the highest concentration among weed pollen. The total pollen concentration was significantly higher in Incheon than in Seoul (p = 0.001 in 2015, p < 0.001 in 2016) and higher in 2016 than in 2015. The concentrations of pollen from weed species (Cupressaceae, Humulus spp., Artemisia spp., Ambrosia spp., and Chenopodiaceae) and grass species (Gramineae) were significantly higher (p < 0.001) than those from tree species. Pollen was distributed from February to November. The first pollen identified in both regions in each year was Alnus spp. Overall, the total concentration of Quercus spp., Betula spp., Humulus spp., Artemisia spp., Ambrosia spp., and Chenopodiaceae pollen increased significantly over the 2 years. CONCLUSION: Region-specific differences exist in the pollen of major allergenic plants. Continuous monitoring of pollen is thus essential for management of pollen-related allergic disorders in each region.


Subject(s)
Humans , Allergens , Alnus , Ambrosia , Artemisia , Asthma , Betula , Chenopodiaceae , Conjunctivitis, Allergic , Diagnosis , Humulus , Hypersensitivity , Pinus , Poaceae , Pollen , Quercus , Rhinitis, Allergic , Seoul , Trees
20.
Asia Pacific Allergy ; (4): 57-64, 2017.
Article in English | WPRIM | ID: wpr-750101

ABSTRACT

Allergic conjunctivitis (AC), which may be acute or chronic, is associated with rhinitis in 30%–70% of affected individuals, hence the term allergic rhinoconjunctivitis (AR/C). Seasonal and perennial AC is generally milder than the more chronic and persistent atopic and vernal keratoconjunctivitis. Natural allergens like house dust mites (HDM), temperate and subtropical grass and tree pollen are important triggers that drive allergic inflammation in AC in the Asia-Pacific region. Climate change, environmental tobacco smoke, pollutants derived from fuel combustion, Asian dust storms originating from central/north Asia and phthalates may also exacerbate AR/C. The Allergies in Asia Pacific study and International Study of Asthma and Allergies in Childhood provide epidemiological data on regional differences in AR/C within the region. AC significantly impacts the quality of life of both children and adults, and these can be measured by validated quality of life questionnaires on AR/C. Management guidelines for AC involve a stepped approach depending on the severity of disease, similar to that for allergic rhinitis and asthma. Topical calcineurin inhibitors are effective in certain types of persistent AC, and sublingual immunotherapy is emerging as an effective treatment option in AR/C to grass pollen and HDM. Translational research predominantly from Japan and Korea involving animal models are important for the potential development of targeted pharmacotherapies for AC.


Subject(s)
Adult , Child , Humans , Allergens , Asia , Asian People , Asthma , Calcineurin Inhibitors , Climate Change , Conjunctivitis, Allergic , Desensitization, Immunologic , Drug Therapy , Dust , Epidemiology , Hypersensitivity , Inflammation , Japan , Korea , Models, Animal , Poaceae , Pollen , Pyroglyphidae , Quality of Life , Rhinitis , Rhinitis, Allergic , Seasons , Smoke , Sublingual Immunotherapy , Tobacco , Translational Research, Biomedical , Trees
SELECTION OF CITATIONS
SEARCH DETAIL